Oncolytics Biotech
ONCY
#9263
Rank
$0.10 B
Marketcap
$0.94
Share price
-4.78%
Change (1 day)
7.35%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -$24.88 Million USD

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$25.45 Million USD a decrease over its 2023 earnings that were of -$25.19 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$24.88 Million-2.23%
2024 -$25.45 Million1.01%
2023 -$25.19 Million23.39%
2022 -$20.42 Million-1.98%
2021 -$20.83 Million9.1%
2020 -$19.09 Million22.64%
2019 -$15.57 Million22.78%
2018 -$12.68 Million4.1%
2017 -$12.18 Million4.87%
2016 -$11.62 Million8.75%
2015 -$10.68 Million-37.06%
2014 -$16.97 Million-26.2%
2013 -$22.99 Million-37.39%
2012 -$36.72 Million28.8%
2011 -$28.51 Million46.02%
2010 -$19.53 Million35.64%
2009 -$14.4 Million-14.2%
2008 -$16.78 Million-0.52%
2007 -$16.87 Million24.6%
2006 -$13.54 Million45.34%
2005 -$9.32 Million-11.8%
2004 -$10.56 Million115.36%
2003 -$4.91 Million13.86%
2002 -$4.31 Million-5.45%
2001 -$4.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-$5.49 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-$29.04 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-$0.77 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA